Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides.

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[2]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). , 2010, Arthritis and rheumatism.

[3]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. , 2010, Arthritis and rheumatism.

[4]  A. Higashi,et al.  Urinary 3‐bromotyrosine and 3‐chlorotyrosine concentrations in asthmatic patients: lack of increase in 3‐bromotyrosine concentration in urine and plasma proteins in aspirin‐induced asthma after intravenous aspirin challenge , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  M. Sanak,et al.  Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. , 2004, The Journal of allergy and clinical immunology.

[6]  A. Higashi,et al.  Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. , 2004, The Journal of allergy and clinical immunology.

[7]  H. Er,et al.  Urinary nitric oxide levels are increased and correlated with plasma concentrations in patients with Behçet's disease: Is it a new urinary activity marker? , 2003, Nephrology.

[8]  C. Rice-Evans,et al.  Nitration of endogenous para-hydroxyphenylacetic acid and the metabolism of nitrotyrosine. , 2003, The Biochemical journal.

[9]  D. Stevenson,et al.  Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. , 2003, The Journal of allergy and clinical immunology.

[10]  N. Higashi,et al.  A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin‐intolerant asthma , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  G. Town,et al.  Eosinophil peroxidase produces hypobromous acid in the airways of stable asthmatics. , 2002, Free radical biology & medicine.

[12]  L. Mastalerz,et al.  Myocardial ischemia possibly mediated by cysteinyl leukotrienes. , 2002, The Journal of allergy and clinical immunology.

[13]  J. Heinecke,et al.  Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. , 2002, Analytical biochemistry.

[14]  P. Weller,et al.  The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report. , 2001, The Journal of allergy and clinical immunology.

[15]  A. Sampson,et al.  Leukotrienes in cardiovascular disease , 2001 .

[16]  S. Hazen,et al.  Eosinophils Are a Major Source of Nitric Oxide-Derived Oxidants in Severe Asthma: Characterization of Pathways Available to Eosinophils for Generating Reactive Nitrogen Species4 , 2001, The Journal of Immunology.

[17]  J. Palmblad,et al.  Human umbilical vein endothelial cells generate leukotriene C4 via microsomal glutathione S-transferase type 2 and express the CysLT(1) receptor. , 2001, European journal of biochemistry.

[18]  R. Robbins,et al.  Methotrexate stimulates lung fibroblasts and epithelial cells to release eosinophil chemotactic activity. , 2001, The Journal of rheumatology.

[19]  S. Hazen,et al.  Myeloperoxidase-generated oxidants and atherosclerosis. , 2000, Free radical biology & medicine.

[20]  S. Hazen,et al.  Eosinophils generate brominating oxidants in allergen-induced asthma. , 2000, The Journal of clinical investigation.

[21]  B. Halliwell,et al.  Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. , 2000, The Biochemical journal.

[22]  S. Holgate.  The epidemic of allergy and asthma , 1999, Nature.

[23]  R J Falk,et al.  International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) , 1999, American journal of clinical pathology.

[24]  S. Hazen,et al.  3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. , 1999, Biochemistry.

[25]  S. Kobayashi,et al.  Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage. , 1998, Arthritis and rheumatism.

[26]  S. L. Hazen,et al.  3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. , 1997, The Journal of clinical investigation.

[27]  M. Kumlin.  Measurements of leukotrienes in the urine: strategies and applications , 1997, Allergy.

[28]  S. L. Hazen,et al.  Human neutrophils employ chlorine gas as an oxidant during phagocytosis. , 1996, The Journal of clinical investigation.

[29]  B. Haynes,et al.  Pathogenic mechanisms of vessel damage in vasculitis syndromes. , 1995, Rheumatic diseases clinics of North America.

[30]  W. Lehmann,et al.  Increased generation of cysteinyl leukotrienes in Kawasaki disease. , 1995, Archives of disease in childhood.

[31]  P. Bozeman,et al.  Oxidation of Bromide by the Human Leukocyte Enzymes Myeloperoxidase and Eosinophil Peroxidase , 1995, The Journal of Biological Chemistry.

[32]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[33]  P. Weller,et al.  Eosinophils: structure and functions. , 1994, Current opinion in immunology.

[34]  T. Haahtela,et al.  Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.

[35]  C. Serhan,et al.  Angioplasty Triggers Intracoronary Leukotrienes and Lipoxin A4: Impact of Aspirin Therapy , 1992, Circulation.

[36]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[37]  P. Tugwell,et al.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. , 1990, Arthritis and rheumatism.

[38]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. , 1989, The American journal of pathology.

[39]  M. Tomonaga,et al.  Molecular cloning and characterization of a chromosomal gene for human eosinophil peroxidase. , 1989, The Journal of biological chemistry.

[40]  L. Pease,et al.  Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family , 1989, The Journal of experimental medicine.

[41]  R. Falk,et al.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. , 1988, The New England journal of medicine.

[42]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[43]  S. Weiss,et al.  Brominating oxidants generated by human eosinophils. , 1986, Science.

[44]  R. Matthay,et al.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs. , 1986, The American review of respiratory disease.

[45]  P. Venge,et al.  Human eosinophil peroxidase: purification and characterization. , 1985, Journal of immunology.

[46]  T. H. The,et al.  AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.

[47]  G. Hughes,et al.  Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg‐Strauss Syndrome , 1984, Medicine.

[48]  R. Lehrer,et al.  Assessment of chlorination by human neutrophils , 1983, Nature.

[49]  S. Weiss,et al.  Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. , 1982, The Journal of clinical investigation.

[50]  W. Henderson,et al.  Bactericidal activity of eosinophil peroxidase. , 1980, Journal of immunology.

[51]  M. Taniguchi,et al.  Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulin. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[52]  L. Guillevin,et al.  Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. , 1999, Medicine.

[53]  R. Matthay,et al.  Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. , 1986, The American review of respiratory disease.

[54]  R. Locksley,et al.  Oxidative response of phagocytes to parasite invasion. , 1983, Ciba Foundation symposium.